Telix Pharmaceuticals Limited ( TLPPF) - Key Metrics
TLPPF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $2 | $0.16 | $0.10 | $0.02 |
| 2025Q4 | $1.86 | -$0.02 | -$0.16 | -$0.28 |
| 2025Q2 | $1.76 | -$0.01 | $0.08 | $0.05 |
| 2024Q4 | $1.79 | $0.12 | $0.01 | -$0.03 |
| 2024Q2 | $0.57 | $0.03 | $0.10 | $0.06 |
TLPPF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 25.22 |
| 2025Q4 | 0% | -133.59 |
| 2025Q2 | 0% | -590.06 |
| 2024Q4 | 0% | 50.41 |
| 2024Q2 | 0% | 133.99 |
TLPPF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 0.11% | 0% |
| 2025Q4 | -2.40% | 0% |
| 2025Q2 | 0.21% | 0% |
| 2024Q4 | -0.14% | 0% |
| 2024Q2 | 0.32% | 0% |
TLPPF
Price: $10.24
52 week price:
Earnings Per Share: 0.10 USD
P/E Ratio: 113.70
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 3.6 billion